Skip to content
Back to search

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Denosumab, ATC M05BX04

AOK Bayern - Die GesundheitskasseGermanyPublished on Aug 13, 2026
720 days left

Description

This is not an open procedure, but an open-house model. The form for the open procedure is only used because there is no form for the open-house model. Contracts concluded under the open-house model do not fall under public procurement law due to the lack of a selection decision. The use of this form does not involve submission to public procurement regulations. AOK Bayern intends to conclude non-exclusive discount agreements with all interested pharmaceutical companies for the active substance Denosumab, ATC M05BX04, in accordance with § 130a Abs.8 SGB V. AOK Bayern offers all interested pharmaceutical companies that meet the eligibility criteria listed below the opportunity to conclude identical and non-individually negotiable discount agreements. The earliest possible contract start date is 01.10.2026; all contracts end on 30.09.2028. A contract can be concluded at any time during this period, but no later than 03.08.2028. The contracts can be terminated with one month's notice to the end of the month. If a discount contract for medicines with the subject matter of the contract comes into force through a nationwide or state-specific open procedure, the open-house agreements will automatically cease to apply for the corresponding term. A contract will be concluded with all interested pharmaceutical companies that demonstrate their eligibility through a completed and signed self-declaration of reliability. The pharmaceutical company must submit the completed and signed (the authorization of the signatory/s must be evident from the commercial register extract, otherwise a power of attorney must be submitted) contract, together with the completed and signed annex "Specification of the contractual medicines" and the completed and signed self-declaration of reliability. The documents can be submitted EITHER IN WRITING by hand-signed OR ELECTRONICALLY with a qualified electronic signature. Hand-signed documents in WRITING must be sent in duplicate in original form to the following address: AOK Bayern - Die Gesundheitskasse Fachbereich Vertragsmanagement AZMV open-house Rabattverträge Carl-Wery-Str. 28 81739 München ELECTRONIC documents with a qualified electronic signature must be submitted via the communication area in the tendering portal www.dtvp.de. If complete and correct documents are received by the 03rd of each month, the contract will commence on the first of the following month, otherwise on the first of the month after next. For hand-signed documents in WRITING, the complete, completed and signed documents must be sent in advance as a scan to the e-mail address [email protected] or via the communication area in the tendering portal www.dtvp.de in a timely manner, if the complete and correct original documents in paper form are received by the AOK Bayern, procurement office, by the 10th of the month. Please note the completion instructions, which will be available under www.dtvp.de with the tender documents. Interested pharmaceutical companies can request the release of the tender documents in the project room for the open-house procedure on the portal www.dtvp.de. A link to the portal is included in this notice. Only pharmaceutical companies are considered as potential contractual partners. The documents of the open-house procedure will be released exclusively to pharmaceutical companies as potential contractual partners and must be treated as strictly confidential. By requesting the release, the companies confirm the confidential treatment of the documents.

CPV codes

Pharmaceutical products

Documents & submission

AI summary
Sign in for an AI summary

Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.

Related tenders